loadpatents
Patent applications and USPTO patent grants for Fattom; Ali Ibrahim.The latest application filed is for "hapten-carrier conjugates for treating and preventing nicotine addiction".
Patent | Date |
---|---|
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 8,026,109 - Ennifar , et al. September 27, 2 | 2011-09-27 |
Hapten-carrier Conjugates For Treating And Preventing Nicotine Addiction App 20110217320 - Ennifar; Sofiane ;   et al. | 2011-09-08 |
Hapten-carrier Conjugates For Treating And Preventing Nicotine Addiction App 20110002957 - Ennifar; Sofiane ;   et al. | 2011-01-06 |
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 7,776,620 - Ennifar , et al. August 17, 2 | 2010-08-17 |
Staphylococcus antibodies Grant 7,531,633 - Pavliak , et al. May 12, 2 | 2009-05-12 |
Use of panton-valentine leukocidin for treating and preventing staphylococcus infections App 20090074755 - Taylor; Kimberly Louise ;   et al. | 2009-03-19 |
Hapten-carrier Conjugates For Treating And Preventing Nicotine Addiction App 20080026000 - Ennifar; Sofiane ;   et al. | 2008-01-31 |
Enterococcus antigens and vaccines Grant 7,291,343 - Fattom , et al. November 6, 2 | 2007-11-06 |
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 7,247,502 - Ennifar , et al. July 24, 2 | 2007-07-24 |
Method of treating staphylococcus aureus infection App 20060153857 - Horwith; Gary ;   et al. | 2006-07-13 |
Compositions of .beta.-glucans and specific antibodies Grant 7,030,101 - Pavliak , et al. April 18, 2 | 2006-04-18 |
Staphylococcus antigen and vaccine Grant 6,936,258 - Pavliak , et al. August 30, 2 | 2005-08-30 |
Hapten-carrier conjugates for treating and preventing nicotine addiction App 20050136047 - Ennifar, Sofiane ;   et al. | 2005-06-23 |
Staphylococcus antigen and vaccine App 20050118190 - Pavliak, Viliam ;   et al. | 2005-06-02 |
Enterococcus antigens and vaccines App 20050008658 - Fattom, Ali Ibrahim ;   et al. | 2005-01-13 |
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 6,773,891 - Ennifar , et al. August 10, 2 | 2004-08-10 |
Enterococcus antigens and vaccines Grant 6,756,361 - Fattom , et al. June 29, 2 | 2004-06-29 |
Hapten-carrier conjugates for treating and preventing nicotine addiction App 20030165950 - Ennifar, Sofiane ;   et al. | 2003-09-04 |
Staphylococcus aureus antigen-containing whole cell vaccine Grant 6,537,559 - Fattom March 25, 2 | 2003-03-25 |
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 6,518,031 - Ennifar , et al. February 11, 2 | 2003-02-11 |
Compositions of beta-glucans and specific IGIV App 20020131969 - Pavliak, Viliam ;   et al. | 2002-09-19 |
Staphylococcus aureus antigen-containing whole cell vaccine App 20020031528 - Fattom, Ali Ibrahim | 2002-03-14 |
Compositions of .beta.-glucans and specific IGIV Grant 6,355,625 - Pavliak , et al. March 12, 2 | 2002-03-12 |
Hapten-carrier conjugates for treating and preventing nicotine addiction App 20020004208 - Ennifar, Sofiane ;   et al. | 2002-01-10 |
Staphylococcus aureus antigen-containing whole cell vaccine Grant 6,294,177 - Fattom September 25, 2 | 2001-09-25 |
Hapten-carrier conjugates for treating and preventing nicotine addiction Grant 6,232,082 - Ennifar , et al. May 15, 2 | 2001-05-15 |
Staphylococcus aureus antigen Grant 6,194,161 - Fattom , et al. February 27, 2 | 2001-02-27 |
Type I surface antigen associated with staphylococcus epidermidis Grant 5,961,975 - Fattom , et al. October 5, 1 | 1999-10-05 |
Staphylococcus aureus B-linked hexosamine antigen Grant 5,770,208 - Fattom , et al. June 23, 1 | 1998-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.